[1]
|
Ghulmiyyah, L. and Sibai, B. (2012) Maternal Mortality from Preeclampsia and Eclampsia. Seminars in Perinatology, 36, 56-59. http://dx.doi.org/10.1053/j.semperi.2011.09.011
|
[2]
|
WHO (2011) Recommendations for Prevention and Treatment of Preeclampsia and Eclampsia. WHO Department of Maternal and Child Health, Geneva.
|
[3]
|
Acquaah-Arhin, R. and Kwakwukume, E.Y. (2003) Trends in Eclampsia in Ghana at Korle-Bu Teaching Hospital, Accra, Ghana. Nigerian Journal of Clinical Practice, 6, 1-4
|
[4]
|
Adamu, Y.M., Salihu, H.M., Sathiakumar, N. and Alexander, G.R. (2003) Maternal Mortality in Northern Nigeria: A Population-Based Study. European Journal of Obstetrics Gynecology and Reproductive Biology, 109, 153-159.
http://dx.doi.org/10.1016/S0301-2115(03)00009-5
|
[5]
|
Igberase, G. and Ebeigbe, P. (2006) Eclampsia: Ten-Years of Experience in a Rural Tertiary Hospital in the Niger Delta, Nigeria. Journal of Obstetrics and Gynaecology, 26, 414-417. http://dx.doi.org/10.1080/01443610600720113
|
[6]
|
WHO (2004) Coverage of Maternity Care: A Listing of Available Information. World Health Organization, Geneva.
|
[7]
|
Shah, A.K. (2009) Preeclampsia/Eclampsia. http://emedicine.medscape.com/article/118427%200-overview
|
[8]
|
Saito, S., Nakashima, A., Sakai M. and Sakai, Y. (2007) The Role of Immune System in Preeclampsia. Molecular Aspect of Medicine, 28, 192-209. http://dx.doi.org/10.1016/j.mam.2007.02.006
|
[9]
|
Duley, L. (2009) The Global Impact of Preeclampsia and Eclampisa. Seminars in Perinatology, 33, 130-137.
http://dx.doi.org/10.1053/j.semperi.2009.02.010
|
[10]
|
Zhou, G.Q., Baranov, V., Zimmermann, W., Grunert, F., Erhard, B., et al. (1997) Highly Specific Monoclonal Antibody Demonstrates That Pregnancy-Specific Glycoprotein (PSG) Is Limited to Syncytiotrophoblast in Human Early and Term Placenta. Placenta, 18, 491-501. http://dx.doi.org/10.1016/0143-4004(77)90002-9
|
[11]
|
Kammerer, R. and Zimmermann, W. (2010) Coevolution of Activating and Inhibitory Receptors within Mammalian Carcinoembryonic Antigen Families. BMC Biology, 8, 12. http://dx.doi.org/10.1186/1741-7007-8-12
|
[12]
|
Harris, S.J., Anthony, F.W., Jones, D.B. and Masson, G.M. (1984) Pregnancy-Specific Beta 1-Glycoprotein: Effect on Lymphocyte Proliferation in Vitro. Journal of Reproductive Immunology, 6, 267-270.
http://dx.doi.org/10.1016/0165-0378(84)90015-9
|
[13]
|
Ha, C.T., Waterhouse, R., Warren, J., Zimmermann, W. and Dveksler, G.S. (2005) N-Glycosylation Is Required for Binding of Murine Pregnancy-Specific Glycoproteins 17 and 19 to the Receptor CD9. American Journal of Reproductive Immunology, 59, 251-258. http://dx.doi.org/10.1111/j.1600-0897.2007.00573.x
|
[14]
|
Martínez, F.F., Knubel, C.P., Sánchez, M.C., Cervi, L. and Motrán, C.C. (2012) Pregnancy-Specific Glycoprotein 1a Activates Dendritic Cells to Provide Signals for Th17-, Th2-, and Treg-Cell Polarization. European Journal of Immunology, 42, 1573-1584. http://dx.doi.org/10.1002/eji.201142140
|
[15]
|
Fialova, L., Kohoutova, B., Pelísková, Z., Malbohan, I. and Mikulíková, L. (1991) Serum Levels of Trophoblast-Specific Beta-1-Globulin (SP1) and Alpha-1-Fetoprotein (AFP) in Pregnant Women with Rheumatoid Arthritis. Ceská Gynekologie, 56, 166-170.
|
[16]
|
Ha, C.T., Wu, J.A., Irmak, S., Lisboa, F.A. and Dizon, A.M.L. (2010) Human Pregnancy Specific Beta-1-Glycoprotein 1 (PSG1) Has a Potential Role in Placental Vascular Morphogenesis. Biology of Reproduction, 83, 27-35.
http://dx.doi.org/10.1095/biolreprod.109.082412
|
[17]
|
Jurisicova, A., Antenos, M., Kapasi, K., Meriano, J. and Casper, R.F. (1999) Variability in the Expression of Trophectodermal Markers Beta-Human Chorionic Gonadotrophin, Human Leukocyte Antigen-G and Pregnancy Specific Beta-1 Glycoprotein by the Human Blastocyst. Human Reproduction, 14, 1852-1858.
http://dx.doi.org/10.1093/humrep/14.7.1852
|
[18]
|
Bersinger, N.A. and Odegard, R.A. (2004) Second and Third-Trimester Serum Levels of Placental Proteins in Preeclampsia and Small-for-Gestational Age Pregnancies. Acta Obstetrics and Gynecology of Scandavania, 83, 37-45.
http://dx.doi.org/10.1111/j.1600-0412.2004.00277.x
|
[19]
|
Pihl, K., Larsen, T., Laursen, I., Krebs, L. and Christiansen, M. (2009) First Trimester Maternal Serum Pregnancy- Specific Beta-1-Glycoprotein (SP1) as a Marker of Adverse Pregnancy Outcome. Prenatal Diagnosis, 29, 1256-1261.
http://dx.doi.org/10.1002/pd.2408
|
[20]
|
Chesley, L.C. (1985) Diagnosis of Preeclampsia. Obstetrics and Gynecology, 65, 423-425.
|
[21]
|
Teran, E., Escudero, C., Moya, W., Flores, M., Vallance, P. and Lopez-Jaramillo, P. (2001) Elevated C-Reactive Protein and Pro-Inflammatory Cytokines in Andean Women with Preeclampsia. International Journal of Obstetrics and Gynecology, 75, 243-249. http://dx.doi.org/10.1016/S0020-7292(01)00499-4
|
[22]
|
Pathare, A., Al Kindi, S., Alnaqdy, A., Daar, S., Knox-Macauly, H. and Dennison, D. (2004) Cytokine Profile of Sickle Cell Disease in Oman. American Journal of Hematology, 77, 323-328. http://dx.doi.org/10.1002/ajh.20196
|
[23]
|
Onyemelukwe, G.C., Ekwempu, C.C. and Alexander, L.C. (1985) Pregnancy Specific Glycoprotein (PSG1) in Normal Pregnancy in Nigeria. Internal Journal of Obstetrics and Gynaecology, 23, 347-349.
http://dx.doi.org/10.1016/0020-7292(85)90032-3
|
[24]
|
Silver, R.M., Heyborne, K.D. and Leslie, K.K. (1993) Pregnancy Specific Beta 1 Glycoprotein (SP-1) in Maternal Serum and Ammiotic Fluid; Pre-Eclampsia, Small for Gestational Age Fetus and Fetal Distress. Placenta, 14, 583-589.
http://dx.doi.org/10.1016/S0143-4004(05)80211-5
|
[25]
|
Horne, C.H., Towler, C.M., Pugh-Humphreys, R.G., Thomson, A.W. and Bohn, H. (1976) Pregnancy Specific Beta-1- Glycoprotein: A Product of the Syncytiotrophoblast. Experientia, 32, 1197-1199.
http://dx.doi.org/10.1007/BF01927624
|
[26]
|
Lin, T.M., Halbert, S.P. and Kiefer, D. (1976) Quantitative Analysis of Pregnancy-Associated Plasma Proteins in Human Placenta. Journal of Clinical Investigations, 57, 466-472. http://dx.doi.org/10.1172/JCI108298
|
[27]
|
Lisboa, F.A., Warren, J., Sulkowski, G., Aparicio, M., David, G., et al. (2011) Pregnancy-Specific Glycoprotein 1 Induces Endothelial Tubulogenesis through Interaction with Cell Surface Proteoglycans. Journal of Biological Chemistry, 286, 7577-7586. http://dx.doi.org/10.1074/jbc.M110.161810
|
[28]
|
Sacks, G., Sargent, I. and Redman, C. (1999) An Innate View of Human Pregnancy. Immunology Today, 20, 114-118.
http://dx.doi.org/10.1016/S0167-5699(98)01393-0
|
[29]
|
Snyder, S.K., Wessner, D.H. Wessells, J.L., Waterhouse, R.M., Zimmermann, W. and Dveksler, G.S. (2001) Pregnancy-Specific-Beta1 Glycoprotein Function as Immunomodulators by Inducing Secretion of IL-10, IL6 and TGF by Human Monocytes. American Journal of Immunology, 45, 205-216.
http://dx.doi.org/10.1111/j.8755-8920.2001.450403.x
|
[30]
|
Blois, S.M., Sulkowski, M., Tirado-Gonzalez, I., Warren, J., Freitag, N., Klabb, B.F., Rifkin, D., Fuss, I., Strober, W. and Dveksler, G.S. (2014) Pregnancy Specific Beta-1 Activates Transformation Growth Factor Beta-1 and Prevent Dextran Sodium Sulfate-Induced Colitis in Mice. Mucosal Immunology, 7, 348-358.
http://dx.doi.org/10.1038/mi.2013.53
|
[31]
|
Masson, G.M., Anthony, F. and Wilson, M. (1983) Value of Schwangerschftsprotein 1 (SP1) and Pregnancy-Associated Plasma Protein A (PAPP-A) in the Clinical Management of Threatened Abortion. British Journal of Obstetrics and Gynaecology, 90, 146-149. http://dx.doi.org/10.1111/j.1471-0528.1983.tb08899.x
|
[32]
|
Tamsen, L., Johansson, S.G. and Axelsson, O. (1983) Pregnancy-Specific Beta 1-Glycoprotein (SP1) in Serum from Women with Pregnancies Complicated by Intrauterine Growth Retardation. Journal of Perinatal Medicine, 11, 19-25.
http://dx.doi.org/10.1515/jpme.1983.11.1.19
|
[33]
|
Arnold, L.L., Doherty, T.M., Flor, A.W., Simon, J.A., Chou, J.Y., Chan, W.Y. and Mansfield, B.C. (1999) Pregnancy- Specific Glycoprotein Gene Expression in Recurrent Aborters: A Potential Correlation to Interleukin-10 Expression. American Journal of Reproductive Immunology, 41, 174-182.
http://dx.doi.org/10.1111/j.1600-0897.1999.tb00530.x
|